Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank
Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
122.15m
Last Price
$3.95
52-Week Range
$2.50 - $6.2491
03/22/2023 04:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808